AI assistant
IMMUNIC, INC. — Director's Dealing 2024
Mar 6, 2024
10196_dirs_2024-03-06_16f6f43d-b93b-4249-ad68-b7a7e22b64ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2024-03-04
Reporting Person: Neermann Joerg (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | Stock Option | $13.63 | D | 29959 | Disposed | 2029-07-22 | Common Stock (29959) | Direct |
| 2024-03-04 | Stock Option | $12.30 | D | 15000 | Disposed | 2030-07-01 | Common Stock (15000) | Direct |
| 2024-03-04 | Stock Option | $14.77 | D | 10000 | Disposed | 2031-06-10 | Common Stock (10000) | Direct |
| 2024-03-04 | Stock Option | $3.40 | D | 10000 | Disposed | 2032-06-15 | Common Stock (10000) | Direct |
| 2024-03-04 | Stock Option | $1.72 | A | 64959 | Acquired | Common Stock (64959) | Direct |
Footnotes
F1: On March 4, 2024, the stockholders of Immunic, Inc. approved a proposal to reduce the exercise price of all employee stock options having an exercise price above $3.00 per share (the "Eligible Options") to the greater of $1.72 and 110% of the closing price on a future repricing date to be set by the Board of Directors. The Board of Directors then determined that the exercise price of all Eligible Options will be repriced to $1.72 per share, which is greater than 110% of the closing price of the Common Stock on March 4, 2024, the repricing date set by the Board of Directors. Accordingly, this Form 4 reflects the cancellation of each Eligible Option and the reissuance of all Eligible Options at an exercise price of $1.72 per share. Following the repricing, each Eligible Option retains its respective original vesting schedule and expiration date.